Muhannad Alomari

Nik Sharma, CEO of BioCorteX and clinician scientist, alongside CTO Muhannad Alomari, explores groundbreaking methods to influence drug efficacy through bacterial interactions. They discuss how emerging computational techniques can reshape personalized medicine and drug development. By applying engineering principles from aerospace to biotech, they highlight the significance of microbiome variations in medication responses. Their innovative Carbon Mirror platform showcases advanced modeling in oncology, offering insights for future biotech collaborations and the importance of unique approaches in drug discovery.